Wasan Mahdi Al-Ghanimi, Noufel Sh. Al-Shadood, Hiba D. Al-Ameri
{"title":"华莉丝国际癌症研究所对中危妇女乳腺癌风险的乳房 X 射线密度估计","authors":"Wasan Mahdi Al-Ghanimi, Noufel Sh. Al-Shadood, Hiba D. Al-Ameri","doi":"10.30574/wjbphs.2024.19.1.0427","DOIUrl":null,"url":null,"abstract":"Introduction: Breast cancer is the second most common malignant tumor worldwide and the leading cause of cancer death among women in developing regions, including the Middle East and North Africa. This study aims to evaluate Mammogram Density Estimation for Assessing Breast Cancer Risk in Intermediate-Risk Women at Warith International Cancer Institution. Methods: The study included 261 women aged 40-78 who visited the Warith International Cancer Institution in Karbala, Iraq, between May 2023 and April 2024. Participants were divided into two groups based on mammographic breast density (MBD) according to the BI-RADS classification: non-dense (fatty and scattered fibroglandular) and dense (heterogeneously dense and dense) breasts. Demographic and clinical data were collected, and the association between breast density and various breast conditions was analyzed using logistic regression. Results: For malignant cases, the odds ratio (OR) for invasive ductal carcinoma (IDC) was 1.04, suggesting no significant difference in the likelihood of IDC between dense and non-dense breasts. The OR for ductal carcinoma in situ (DCIS) was 1.60, indicating a slightly higher, but not statistically significant, likelihood of DCIS in dense breasts. The overall OR for malignant cases was 1.26, showing a trend towards a higher likelihood of malignancy in dense breasts, but it was not statistically significant. For benign conditions, the OR for fibrocystic changes was 1.76, suggesting a higher likelihood in dense breasts, but the results were not statistically significant. Similarly, the ORs for fibroadenoma (1.27) and simple cysts (1.40) showed a slight increase in dense breasts but without statistical significance. Abscess and duct ectasia were less likely in dense breasts, but the results were not statistically significant. Conclusion: The study findings suggest that some breast conditions may be more common in dense breasts, but the differences are not statistically significant in many cases. Further targeted research is needed to understand better the relationships between breast density and various breast pathologies.","PeriodicalId":23738,"journal":{"name":"World Journal of Biology Pharmacy and Health Sciences","volume":"16 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mammogram density estimation as breast cancer risk in intermediate-risk women in Warith International Cancer Institution\",\"authors\":\"Wasan Mahdi Al-Ghanimi, Noufel Sh. Al-Shadood, Hiba D. Al-Ameri\",\"doi\":\"10.30574/wjbphs.2024.19.1.0427\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Breast cancer is the second most common malignant tumor worldwide and the leading cause of cancer death among women in developing regions, including the Middle East and North Africa. This study aims to evaluate Mammogram Density Estimation for Assessing Breast Cancer Risk in Intermediate-Risk Women at Warith International Cancer Institution. Methods: The study included 261 women aged 40-78 who visited the Warith International Cancer Institution in Karbala, Iraq, between May 2023 and April 2024. Participants were divided into two groups based on mammographic breast density (MBD) according to the BI-RADS classification: non-dense (fatty and scattered fibroglandular) and dense (heterogeneously dense and dense) breasts. Demographic and clinical data were collected, and the association between breast density and various breast conditions was analyzed using logistic regression. Results: For malignant cases, the odds ratio (OR) for invasive ductal carcinoma (IDC) was 1.04, suggesting no significant difference in the likelihood of IDC between dense and non-dense breasts. The OR for ductal carcinoma in situ (DCIS) was 1.60, indicating a slightly higher, but not statistically significant, likelihood of DCIS in dense breasts. The overall OR for malignant cases was 1.26, showing a trend towards a higher likelihood of malignancy in dense breasts, but it was not statistically significant. For benign conditions, the OR for fibrocystic changes was 1.76, suggesting a higher likelihood in dense breasts, but the results were not statistically significant. Similarly, the ORs for fibroadenoma (1.27) and simple cysts (1.40) showed a slight increase in dense breasts but without statistical significance. Abscess and duct ectasia were less likely in dense breasts, but the results were not statistically significant. Conclusion: The study findings suggest that some breast conditions may be more common in dense breasts, but the differences are not statistically significant in many cases. Further targeted research is needed to understand better the relationships between breast density and various breast pathologies.\",\"PeriodicalId\":23738,\"journal\":{\"name\":\"World Journal of Biology Pharmacy and Health Sciences\",\"volume\":\"16 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Biology Pharmacy and Health Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30574/wjbphs.2024.19.1.0427\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Biology Pharmacy and Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30574/wjbphs.2024.19.1.0427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
导言:乳腺癌是全球第二大最常见的恶性肿瘤,也是包括中东和北非在内的发展中地区妇女癌症死亡的主要原因。本研究旨在评估华理斯国际癌症研究所采用乳腺 X 线造影密度估算法评估中危妇女乳腺癌风险的情况。研究方法研究对象包括 2023 年 5 月至 2024 年 4 月期间前往伊拉克卡尔巴拉 Warith 国际癌症研究所就诊的 261 名 40-78 岁女性。根据 BI-RADS 分类法,按照乳房X线照相术乳房密度(MBD)将参与者分为两组:非致密型(脂肪型和散在纤维腺型)和致密型(异质致密型和致密型)乳房。研究人员收集了人口统计学和临床数据,并使用逻辑回归分析了乳腺密度与各种乳腺疾病之间的关联。结果显示在恶性病例中,浸润性导管癌(IDC)的几率比(OR)为 1.04,这表明致密乳房和非致密乳房患 IDC 的可能性没有显著差异。导管原位癌(DCIS)的OR值为1.60,表明致密乳房发生DCIS的可能性略高,但无统计学意义。恶性病例的总体 OR 值为 1.26,表明致密乳房发生恶性病变的可能性呈上升趋势,但无统计学意义。就良性病变而言,纤维囊性病变的 OR 值为 1.76,表明致密乳房发生良性病变的可能性较高,但结果无统计学意义。同样,乳腺纤维腺瘤(1.27)和单纯囊肿(1.40)的 OR 值在致密乳房中略有增加,但无统计学意义。致密乳房发生脓肿和导管异位的几率较低,但结果在统计学上无显著意义。结论研究结果表明,某些乳腺疾病可能在致密型乳房中更为常见,但在许多情况下差异并不具有统计学意义。要更好地了解乳房密度与各种乳房病变之间的关系,还需要进一步开展有针对性的研究。
Mammogram density estimation as breast cancer risk in intermediate-risk women in Warith International Cancer Institution
Introduction: Breast cancer is the second most common malignant tumor worldwide and the leading cause of cancer death among women in developing regions, including the Middle East and North Africa. This study aims to evaluate Mammogram Density Estimation for Assessing Breast Cancer Risk in Intermediate-Risk Women at Warith International Cancer Institution. Methods: The study included 261 women aged 40-78 who visited the Warith International Cancer Institution in Karbala, Iraq, between May 2023 and April 2024. Participants were divided into two groups based on mammographic breast density (MBD) according to the BI-RADS classification: non-dense (fatty and scattered fibroglandular) and dense (heterogeneously dense and dense) breasts. Demographic and clinical data were collected, and the association between breast density and various breast conditions was analyzed using logistic regression. Results: For malignant cases, the odds ratio (OR) for invasive ductal carcinoma (IDC) was 1.04, suggesting no significant difference in the likelihood of IDC between dense and non-dense breasts. The OR for ductal carcinoma in situ (DCIS) was 1.60, indicating a slightly higher, but not statistically significant, likelihood of DCIS in dense breasts. The overall OR for malignant cases was 1.26, showing a trend towards a higher likelihood of malignancy in dense breasts, but it was not statistically significant. For benign conditions, the OR for fibrocystic changes was 1.76, suggesting a higher likelihood in dense breasts, but the results were not statistically significant. Similarly, the ORs for fibroadenoma (1.27) and simple cysts (1.40) showed a slight increase in dense breasts but without statistical significance. Abscess and duct ectasia were less likely in dense breasts, but the results were not statistically significant. Conclusion: The study findings suggest that some breast conditions may be more common in dense breasts, but the differences are not statistically significant in many cases. Further targeted research is needed to understand better the relationships between breast density and various breast pathologies.